About HealthCap
HealthCap is a private equity firm founded in 1996. It is primarily based in Dallas, United States.
Overall HealthCap portfolio has seen 4 acquisitions, namely Bon Secours, Wilson Therapeutics and Bellus Medical. A lot of funds co-invest with HealthCap, with names like Arch Venture Partners sharing a substantial percentage of its portfolio.
HealthCap has a team of 4 people, including 3 partners.
Key Metrics
HealthCap's Portfolio
They have invested in a total of 15 companies. Their most recent investment was in Pretzel (Series A round) on Sep 12, 2022. Here is the most recent investment by HealthCap:Date | Company | Round | Amount | Co-Investors |
|---|---|---|---|---|
Sep 12, 2022 | Series A | 5969 | ||
2015 | Seed | 3317 | - | |
Apr 14, 2014 | Series B | 6622 | and 1 others | |
Jul 02, 2013 | Post IPO | 5984 |
Here is the portfolio snapshot of HealthCap:
Investments by Year
The maximum number of investments were made in 2022
Team profile of HealthCap
HealthCap has a team of 4 members including 3 Partners and 1 Principal located in United States. HealthCap's team does not sit on the board of any company as of now.Here is a list of all team members in HealthCap:
Name | Designation | Location | Board Memberships | Contact Details |
|---|---|---|---|---|
Partner | Dallas | - | ||
Partner | Dallas | - | ||
Partner | Dallas | - | ||
Principal | Dallas | - |
Co-investors of HealthCap
Over the past 30 years, 16 investors have co-invested in HealthCap's portfolio companies.
- Top Co-investors of HealthCap: 16 investors entered a company along with HealthCap. These include investors like Arch Venture Partners (1 company).
HealthCap News
•
Finnish Healthtech Startup CurifyLabs Raises €12 Million in Series A RoundStartup Rise EU•Jul 06, 2026•Healthcap, CurifyLabs, Sandwater, HealthCap and 1 other
•
Priothera lands Series AVCJ•Oct 12, 2020•Priothera, Fountain Healthcare Partners, Healthcap, Tekla Capital Management and 2 others
•
Spruce Biosciences Raises $88 Million in Series B Financing, co-led by Omega Funds and AbingworthBusiness Wire•Feb 19, 2020•Spruce Biosciences, Omega Funds, Abingworth, Novo Holdings and 7 others